{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:7067174",
      "entity_text" : "daunorubicin",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06314",
      "entity_text" : "CrEL",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "CrEL increased the sensitivity of multidrug resistant cells to daunorubicin at concentrations over 0.1 muL/mL (0.01%) and completely reversed the resistance at 2.0 muL/mL (0.2%) [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-08T14:07:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:04:41Z",
  "trigger" : "increased",
  "evidence" : [ "CrEL increased the sensitivity of multidrug-resistant cells to daunorubicin" ],
  "pmc_id" : "3362138",
  "score" : 0
}